Several institutions have published guidance on how to treat patients hospitalized with COVID-19.
A new study found that switching from a primary national plan of egg-based vaccines to cell-based vaccines for the flu would significantly reduce the impact of the seasonal virus at a lesser production and distribution cost.
Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
The 2024 National Impact Assessment of CMS Quality Measures Report found that adherence to medications for cholesterol, hypertension and diabetes helped Medicare beneficiaries avoid up to $29.2 billion dollars in health care costs from 2016-21.
The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.
The remote and virtual way of treating patients is becoming the new norm. Specialty providers have to adapt to provide the most streamlined solutions.
Pharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
IBS in pediatric patients has not been studied much, but new data reveals a possible treatment.